Pharming Group N.V. Announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was EUR 36.042 million compared to EUR 49.294 million a year ago. Operating income was EUR 5.198 million compared to EUR 19.446 million a year ago. Net income was EUR 7.051 million compared to EUR 8.427 million a year ago. Basic earnings per share from continuing operations was EUR 0.011 compared to EUR 0.013 a year ago. Diluted earnings per share from continuing operations was EUR 0.011 compared to EUR 0.011 a year ago.